HIPEC for colorectal peritoneal metastases. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

HIPEC for colorectal peritoneal metastases.

Samuel J Klempner, David P Ryan

Author Information

Samuel J Klempner: Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA.
David P Ryan: Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA. Electronic address: dpryan@mgh.harvard.edu.

PMID: 33476594 DOI: 10.1016/S1470-2045(20)30693-8

No abstract text available.

Colorectal Neoplasms

Cytoreduction Surgical Procedures

Humans

Hyperthermia, Induced

Hyperthermic Intraperitoneal Chemotherapy

Peritoneal Neoplasms

Journal Article Comment

Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer.Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review.Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy (HIPEC) For Colorectal Peritoneal Metastases.PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases.Investigating locations of recurrences with MRI after CRS-HIPEC for colorectal peritoneal metastases.The importance of integrating diagnostic modalities in patient selection for CRS-HIPEC in colorectal peritoneal metastases.Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7.

Tailored chemotherapy for colorectal cancer peritoneal metastases based on a drug-screening platform in patient-derived organoids: a case report.Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study.5-aza-2'-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages.A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal Tumors and Comprehensive Genomic Profiling Analysis of 20 Cases.Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin.Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review.Exploring the effects of taurolidine on tumor weight and microvessel density in a murine model of osteosarcoma.Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers.Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.

See all "Cited by" articles